Disability, Work Absenteeism, Sickness Benefits, and Cancer in Selected European OECD Countries-Forecasts to 2020.

scientific article

Disability, Work Absenteeism, Sickness Benefits, and Cancer in Selected European OECD Countries-Forecasts to 2020. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3389/FPUBH.2017.00023
P932PMC publication ID5327442
P698PubMed publication ID28289676

P50authorMihajlo B. JakovljevicQ42305947
Nemanja RancicQ56951810
Olivera MilovanovicQ86302420
P2093author name stringDubravko Bokonjic
Christina Malmose-Stapelfeldt
P2860cites workGlobal, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015Q27468570
Legal Framework and Retirement Policies in Serbia from 1990 to 2016 - Gendered PerspectiveQ28078590
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015.Q30061943
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.Q30353189
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Q30353195
Unemployment, labor force composition and sickness absence: a panel data studyQ30985723
Out of sight, not out of mind: strategies for handling missing dataQ31136936
LAT software induced savings on medical costs of alcohol addicts' care--results from a matched-pairs case-control studyQ34472874
NICE guidance on long-term sickness and incapacity.Q34617687
Migrant integration policies and health inequalities in EuropeQ36036644
Growth of Global Health Spending Share in Low and Middle Income Countries.Q36574845
The New and Old Europe: East-West Split in Pharmaceutical SpendingQ36633030
Cancer and disability benefits: a synthesis of qualitative findings on advice and supportQ36935467
Controlling sickness absence: a study of changes in the Danish sickness absence legislation since 1973.Q37006479
Evolving Health Expenditure Landscape of the BRICS Nations and Projections to 2025.Q38816604
Comparison of historical medical spending patterns among the BRICS and G7.Q38964362
Impact of a facility-based corporate fitness program on the number of absences from work due to illnessQ39102351
Radiation therapy remains the key cost driver of oncology inpatient treatmentQ39121086
A ten-year study of depressive symptoms in Serbian medical students.Q39347227
The growth in the Social Security Disability rolls: a fiscal crisis unfoldingQ40259194
Life expectancy and health expenditure evolution in Eastern Europe-DiD and DEA analysisQ40275719
Forecasting health expenditures: short, medium, and long (long) termQ40772716
Impact of imaging diagnostics on the budget--are we spending too much?Q43637700
Economic burden of cancer across the European Union: a population-based cost analysisQ43937749
Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.Q44916903
Resource allocation strategies in Southeastern European health policyQ46173098
Factors affecting short-term rehabilitation outcomes of disabled elderly patients with proximal hip fracture.Q51902018
Population aging and the growth of health expendituresQ52421571
Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma.Q54311727
Chapter 1 International comparisons of health expenditure: Theory, data and econometric analysisQ57656559
Macroeconomic Policy Impact On Oncology-Related Public Expenditure In An Emerging European Market – Signs Of Early RecoveryQ58440259
Craniocerebral injuries in traffic accidents with fatal outcomesQ58440278
Health Financing Constrained by Population Aging - An Opportunity to Learn from Japanese Experience / Finansiranje Zdravstvene Zaštite U Uslovima Starenja Popualcije - Prilika Da Učimo Na Japanskom IskustvuQ58440283
Reduced disability and health care costs in an industrial fitness programQ70678105
Work-system risk factors for permanent work disability among home-care workers: a case-control studyQ73257436
P921main subjectdisabilityQ12131
absenteeismQ332278
P304page(s)23
P577publication date2017-02-27
P1433published inFrontiers in Public HealthQ27725050
P1476titleDisability, Work Absenteeism, Sickness Benefits, and Cancer in Selected European OECD Countries-Forecasts to 2020.
P478volume5

Reverse relations

cites work (P2860)
Q55252920A finite and stable exponential growth-adjusted indirect cost of cancer associated with discounted years of life lost in Saudi Arabia.
Q47774543Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study
Q46742226Incremental cost and cost-effectiveness of low-dose, high-frequency training in basic emergency obstetric and newborn care as compared to status quo: part of a cluster-randomized training intervention evaluation in Ghana
Q33804329Trends and Patterns of Disparities in Oral Cavity and Pharyngeal Cancer in Serbia: Prevalence and Economic Consequences in a Transitional Country

Search more.